compounded tirzepatide vs semaglutide Standard Dose Microdose GLP-1: & – PlexusDx Efficacy of tirzepatide 5, 10

Increased Energy Levels Shedding excess weight boosts energy, allowing you to enjoy the vibrant, fast-paced NYC lifestyle

Retatrutide at the 12 mg dose with 24.2% over 48 weeks (TRIUMPH-1, NEJM 2023), followed by tirzepatide at 15 mg with 20.9% over 72 weeks (SURMOUNT-1), then semaglutide at 2.4 mg with 14.9% over 68 weeks (STEP-1)

If salmon is too expensive, canned tuna or 99% lean ground turkey hits the same protein at half the cost

(source: prnewswire.com) GLP-1 Analogues Market Segmentation By Route of Administration Outlook Subcutaneous Route Oral Route By Product Outlook Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Victoza Zepbound Other Products By Application Outlook Type 2 Diabetes Mellitus Obesity Others Applications By Distribution Channel Outlook Hospital Pharmacies Retail Pharmacies Online Pharmacies By Regional Outlook North America US Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Analogues Market Report Scope Source: Polaris Market Research Analysis GLP-1 Analogues Market FAQ's The global GLP-1 analogues market size was valued at USD 56.62 billion in 2025